6-14117976-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004233.4(CD83):c.64G>A(p.Glu22Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000435 in 1,610,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004233.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD83 | NM_004233.4 | c.64G>A | p.Glu22Lys | missense_variant | Exon 2 of 5 | ENST00000379153.4 | NP_004224.1 | |
CD83 | NM_001040280.3 | c.64G>A | p.Glu22Lys | missense_variant | Exon 2 of 5 | NP_001035370.1 | ||
CD83 | NM_001251901.1 | c.-114G>A | 5_prime_UTR_variant | Exon 2 of 5 | NP_001238830.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD83 | ENST00000379153.4 | c.64G>A | p.Glu22Lys | missense_variant | Exon 2 of 5 | 1 | NM_004233.4 | ENSP00000368450.3 | ||
CD83 | ENST00000612003 | c.-114G>A | 5_prime_UTR_variant | Exon 2 of 5 | 4 | ENSP00000480760.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152134Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000406 AC: 1AN: 246282Hom.: 0 AF XY: 0.00000748 AC XY: 1AN XY: 133616
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1458310Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 725496
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152252Hom.: 0 Cov.: 31 AF XY: 0.0000537 AC XY: 4AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.64G>A (p.E22K) alteration is located in exon 2 (coding exon 2) of the CD83 gene. This alteration results from a G to A substitution at nucleotide position 64, causing the glutamic acid (E) at amino acid position 22 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at